Alphatec Holdings, Inc. reported a strong Q4 and full year 2021, with record revenue and significant growth driven by the adoption of innovative spine surgery solutions and the integration of EOS imaging. The company's focus on surgeon trust and clinically distinct technology contributed to its sector-leading growth.
ATEC reported the highest revenue on record for 2021.
ATEC's lateral procedures delivered over 40% of Q4 revenue growth, driven by the adoption of Prone Trans-Psoas (PTP) Technique.
ATEC trained over 400 surgeons in 2021, contributing to a 23% increase in surgeon users in Q4 compared to the prior year.
ATEC generated $12.8 million in EOS-related revenue, showing momentum in sales, product development, and data management.
The Company continues to expect total revenue for the fiscal year ended December 31, 2022, to approximate $305 million, reflecting growth of approximately 25% compared to the full year 2021. This includes organic revenue growth of 23% and approximately $45 million of revenue related to EOS imaging.
Analyze how earnings announcements historically affect stock price performance